Published in Drug Dev Ind Pharm on March 01, 1999
Co-solvent evaporation method for enhancement of solubility and dissolution rate of poorly aqueous soluble drug simvastatin: in vitro-in vivo evaluation. AAPS PharmSciTech (2008) 1.10
Dissolution improvement of high drug-loaded solid dispersion. AAPS PharmSciTech (2006) 0.88
Mixture experiment methods in the development and optimization of microemulsion formulations. J Pharm Biomed Anal (2011) 1.51
Genetic diversity and reproductive biology in ecotypes of the facultative apomict Hypericum perforatum L. Heredity (Edinb) (2006) 1.15
Development and evaluation of glyburide fast dissolving tablets using solid dispersion technique. Drug Dev Ind Pharm (2004) 1.09
Metformin-associated lactic acidosis requiring hospitalization. A national 10 year survey and a systematic literature review. Eur Rev Med Pharmacol Sci (2013) 1.08
[Usefulness of biological markers in the evaluation of smoking at the first visit of a smoking cessation program]. Rev Mal Respir (2004) 1.07
The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-beta-cyclodextrin. Eur J Pharm Sci (2001) 1.02
Compatibility study between ibuproxam and pharmaceutical excipients using differential scanning calorimetry, hot-stage microscopy and scanning electron microscopy. J Pharm Biomed Anal (1998) 1.00
Investigation of the effects of grinding and co-grinding on physicochemical properties of glisentide. J Pharm Biomed Anal (2002) 0.98
Evaluation of transcutol as a clonazepam transdermal permeation enhancer from hydrophilic gel formulations. Eur J Pharm Sci (2000) 0.96
Influence of the preparation method on the physicochemical properties of ketoprofen-cyclodextrin binary systems. Int J Pharm (1999) 0.91
Characterization of ibuproxam binary and ternary dispersions with hydrophilic carriers. Drug Dev Ind Pharm (2004) 0.91
Influence of cyclodextrins and chitosan, separately or in combination, on glyburide solubility and permeability. Eur J Pharm Biopharm (2005) 0.91
Development of enteric-coated timed-release matrix tablets for colon targeting. J Drug Target (2004) 0.90
Influence of chitosan and its glutamate and hydrochloride salts on naproxen dissolution rate and permeation across Caco-2 cells. Int J Pharm (2004) 0.89
Effects of grinding with microcrystalline cellulose and cyclodextrins on the ketoprofen physicochemical properties. Drug Dev Ind Pharm (2001) 0.88
Optimization of dissolution test precision for a ketoprofen oral extended-release product. J Pharm Biomed Anal (2003) 0.86
Effect of water-soluble polymers on naproxen complexation with natural and chemically modified beta-cyclodextrins. Drug Dev Ind Pharm (2001) 0.86
Determination of stability constant values of flurbiprofen-cyclodextrin complexes using different techniques. J Pharm Biomed Anal (2005) 0.85
New "drug-in cyclodextrin-in deformable liposomes" formulations to improve the therapeutic efficacy of local anaesthetics. Int J Pharm (2010) 0.84
Experimental design in the development of voltammetric method for the assay of omeprazole. J Pharm Biomed Anal (1996) 0.84
Characterization of physicochemical properties of naproxen systems with amorphous beta-cyclodextrin-epichlorohydrin polymers. J Pharm Biomed Anal (2002) 0.84
Microspheres for colonic delivery of ketoprofen-hydroxypropyl-beta-cyclodextrin complex. Eur J Pharm Sci (2008) 0.83
Linezolid-induced thrombocytopenia in impaired renal function: is it time for a dose adjustment? A case report and review of literature. Eur J Clin Pharmacol (2014) 0.83
1,2-Cyclomethylenecarboxylic monoamide hydroxamic derivatives. A novel class of non-amino acid angiotensin converting enzyme inhibitors. J Med Chem (1993) 0.82
Physical characterization of picotamide monohydrate and anhydrous picotamide. J Pharm Sci (1999) 0.82
Simultaneous effect of cyclodextrin complexation, pH, and hydrophilic polymers on naproxen solubilization. J Pharm Biomed Anal (2006) 0.81
Enhancement of dehydroepiandrosterone solubility and bioavailability by ternary complexation with alpha-cyclodextrin and glycine. J Pharm Sci (2003) 0.81
[Preservability of rat serum in delayed determinations of some hematochemical parameters]. Boll Chim Farm (1972) 0.81
Photostability studies on nicardipine-cyclodextrin complexes by capillary electrophoresis. J Pharm Biomed Anal (2004) 0.81
Formulation and characterization of triclosan sub-micron emulsions and nanocapsules. J Microencapsul (2004) 0.81
How experimental design can improve the validation process. Studies in pharmaceutical analysis. Anal Bioanal Chem (2003) 0.81
Scaling breakdown: a signature of aging. Phys Rev E Stat Nonlin Soft Matter Phys (2002) 0.81
Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery. Eur J Pharm Biopharm (2011) 0.80
Thermal analysis as a screening technique in preformulation studies of picotamide solid dosage forms. Drug Dev Ind Pharm (1998) 0.80
Improvement of oxaprozin solubility and permeability by the combined use of cyclodextrin, chitosan, and bile components. Eur J Pharm Biopharm (2011) 0.79
Influence of vehicle composition variations on the in vitro and ex vivo clonazepam diffusion from hydrophilic ointment bases. Pharm Acta Helv (1996) 0.79
Quality by design approach for developing chitosan-Ca-alginate microspheres for colon delivery of celecoxib-hydroxypropyl-β-cyclodextrin-PVP complex. Eur J Pharm Biopharm (2011) 0.79
Antimuscarinic drugs: traditional and potential new therapeutic agents. Pharmacol Res Commun (1982) 0.78
Analysis of gene expression during flowering in apomeiotic mutants of Medicago spp.: cloning of ESTs and candidate genes for 2n eggs. Sex Plant Reprod (2001) 0.78
Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems. Int J Pharm (2007) 0.78
Carbon-13 nuclear magnetic resonance study of naproxen interaction with cyclodextrins in solution. J Pharm Sci (1991) 0.77
Buflomedil is a potent interfering substance in immunoassays of tricyclic antidepressants. J Anal Toxicol (1998) 0.77
Assessment of solid-state interactions of naproxen with amorphous cyclodextrin derivatives by DSC. J Pharm Biomed Anal (2002) 0.77
Response surface methodology in the optimization of chitosan-Ca pectinate bead formulations. Eur J Pharm Sci (2008) 0.77
Chlorophacinone intoxication. A biological and toxicological study. J Toxicol Clin Toxicol (1989) 0.76
Influence of the preparation method on the physicochemical properties of binary systems of econazole with cyclodextrins. Int J Pharm (1999) 0.76
Benzathine as a cause for a false-positive test result for amphetamines. J Pediatr (1995) 0.75
Optimisation and validation of a capillary electrophoresis method for the simultaneous determination of diazepam and otilonium bromide. Analyst (2001) 0.75
Differential scanning calorimetry as a screening technique in compatibility studies of DHEA extended release formulations. J Pharm Biomed Anal (2006) 0.75
[Studies on the in vitro absorption of guaiacolylacetylsalicylate]. Farmaco Prat (1986) 0.75
[Effect of the association of phenformin and chlorpropamide on blood sugar and lactic acid in the guinea pig. I]. Boll Chim Farm (1971) 0.75
Differential pulse polarographic determination of thiomersal transported through an artificial membrane simulating an isolated rabbit cornea. Boll Chim Farm (1980) 0.75
Bioavailability and clinical usefulness of low-strength tablets of phenytoin. Farmaco Prat (1986) 0.75
Determination of flubendazole in pharmaceutical dosage forms by differential pulse polarography and UV spectroscopy. Farmaco (1990) 0.75
[In vitro study of some factors influencing the diffusion of oxytetracycline chloride from hard gelatin capsules]. Boll Chim Farm (1984) 0.75
[The effect of pH on the in vitro absorption of diazepam]. Pharm Acta Helv (1987) 0.75
Pharmacokinetics of cicloxilic acid in the rat. Arzneimittelforschung (1978) 0.75
Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets. Farmaco (2005) 0.75
[Musculo-skeletal disorders and diseases in the complex metal-mechanical industry]. G Ital Med Lav Ergon (2006) 0.75
[Removal of impacted teeth. Indications and contraindications]. Dent Cadmos (1990) 0.75
Effect of cicloxilic acid on the liver damage produced by a choline-free, high-fat low-protein diet. Arzneimittelforschung (1978) 0.75
1H-NMR and molecular modelling techniques for the investigation of the inclusion complex of econazole with alpha-cyclodextrin in the presence of malic acid. J Pharm Biomed Anal (2000) 0.75
[Comparative activity of some biguanides, sulfonylureas and their combinations on blood sugar and lactic acid in the guinea pig. II]. Boll Chim Farm (1971) 0.75
Simultaneous determination of progabide and its acid metabolite by reversed-phase high-performance liquid chromatography. J Chromatogr (1990) 0.75
[In vitro study on the changes in gastrointestinal absorption rate of drugs in the presence of various food components]. Farmaco Prat (1979) 0.75
[Cephalometric study of skeletal-facial changes in oral respiration from obstruction]. Mondo Ortod (1990) 0.75
Development and validation of a differential pulse polarographic method for quinolinic acid determination in human plasma and urine after solid-phase extraction: a chemometric approach. J Pharm Biomed Anal (1998) 0.75
[In-vitro transfer of oxytetracycline and doxycycline from various types of ointment excipients]. Boll Chim Farm (1976) 0.75
On the absorption, distribution and excretion of sorbinicate in the rat and the monkey. Arzneimittelforschung (1982) 0.75
[Derivatives of 1,3-diphenylpropanol and their pharmacologic properties]. Boll Chim Farm (1965) 0.75
Release of drugs in vitro from different dermatological preparations. Boll Chim Farm (1980) 0.75
[New in vitro research in the field of corneal absorption by means of artificial membranes]. Farmaco Prat (1977) 0.75
Storage study on acidic aqueous hexetidine solutions in polyolefinic and glass containers. Boll Chim Farm (1980) 0.75
Biological Properties of IRIM, the Iridium(III) Analogue of (Imidazolium (Bisimidazole) Tetrachlororuthenate) (ICR). Met Based Drugs (2000) 0.75
[Synthesis and pharmaceutical findings on a series of amido derivatives of 3,4,5-trimethoxycinnamoyl acid and its analogs]. Boll Chim Farm (1967) 0.75
Phase equilibria, crystallinity and dissolution rates of ibuprofen-polyethylene glycol 20000 solid dispersions. Farmaco Prat (1987) 0.75
[Condensation of 2,3-dimethyl-4-carbetoxyisoxazoline-5-one with aromatic aldehydes]. Boll Chim Farm (1976) 0.75
Influence of cross-linking agent type and chitosan content on the performance of pectinate-chitosan beads aimed for colon-specific drug delivery. Drug Dev Ind Pharm (2011) 0.75
Adsorptive stripping voltammetry for thiomersal assay. J Pharm Biomed Anal (1994) 0.75
Effects of cicloxilic acid on CCl4-induced liver injury. Arzneimittelforschung (1978) 0.75
[In vitro studies of the diffusion of acetylsalicylic acid from various suppository excipients]. Farmaco Prat (1980) 0.75
Association of thymostimulin to antimycobacterial polychemotherapy in pulmonary tuberculosis. J Chemother (1989) 0.75
[In-vitro study on the diffusion velocity constants of p-2-(n-octyloxy)-benzoyl-aminobenzoate of N-diethylmethylammonioethyl bromide]. Boll Chim Farm (1976) 0.75
In vitro studies of simulated percutaneous absorption: influence of various enhancers in the release of clonazepam from 2-hydroxyethyl acetate patches. Pharm Acta Helv (1998) 0.75
Solid dispersions of ibuprofen in urea. Effects of urea on dissolution. Farmaco Prat (1986) 0.75
Electrically induced contractile phenomena in charged polymer networks: preliminary study on the feasibility of muscle-like structures. Trans Am Soc Artif Intern Organs (1985) 0.75
Preparation and dissolution characteristics of solid dispersions of ibuprofen in various polyethylene glycols. Farmaco Prat (1987) 0.75
Near-infrared reflectance spectrometry in the study of atopy. Part 2. Interactions between the skin and polyethylene glycol 400, isopropyl myristate and hydrogel. Analyst (1997) 0.75
[Availability of phenformin in an oral sustained-release form]. Boll Chim Farm (1973) 0.75
Interaction of naproxen with alpha-cyclodextrin and its noncyclic analog maltohexaose. Pharm Res (1999) 0.75
[In vitro studies on the rates of intestinal absorption of sparsely soluble drugs of different particle size]. Boll Chim Farm (1980) 0.75
Formulation factors influencing the release of clonazepam from a carbopol hydrogel. Boll Chim Farm (1989) 0.75